Inventor
SCHAFFER DAVID
US16 patents
⚠️ This page may combine multiple inventors who share the name “SCHAFFER DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
4D MOLECULAR THERAPEUTICS INC
14 patentsUS11118192B2Sep 14, 2021
Adeno-associated virus variant capsids and methods of use thereof
4D MOLECULAR THERAPEUTICS INC15 citations93
US11613766B2Mar 28, 2023
Adeno-associated virus variant capsids and methods of use thereof
4D MOLECULAR THERAPEUTICS INC4 citations84
US11167041B2Nov 9, 2021
Adeno-associated virus variant capsids and methods of use thereof
4D MOLECULAR THERAPEUTICS INC8 citations82
US11766489B2Sep 26, 2023
Adeno-associated virus variant capsids and use for inhibiting angiogenesis
4D MOLECULAR THERAPEUTICS INC5 citations73
US11802278B2Oct 31, 2023
Codon optimized GLA genes and uses thereof
4D MOLECULAR THERAPEUTICS INC3 citations71
US11345930B2May 31, 2022
Codon optimized RPGRORF15 genes and uses thereof
4D MOLECULAR THERAPEUTICS INC2 citations71
US11198858B2Dec 14, 2021
Codon optimized GLA genes and uses thereof
4D MOLECULAR THERAPEUTICS INC2 citations71
US12221616B2Feb 11, 2025
Adeno-associated virus variant capsids and methods of use thereof
4D MOLECULAR THERAPEUTICS INC0 citations61
US11840704B2Dec 12, 2023
Adeno-associated virus variant capsids and methods of use thereof
4D MOLECULAR THERAPEUTICS INC0 citations61
US11766487B2Sep 26, 2023
Treatments for retinal disease
4D MOLECULAR THERAPEUTICS INC0 citations61
US11576983B2Feb 14, 2023
Treatments for retinal disease
4D MOLECULAR THERAPEUTICS INC0 citations61
US11419949B2Aug 23, 2022
Adeno-associated virus variant capsids and methods of use thereof
4D MOLECULAR THERAPEUTICS INC0 citations61
US11364308B2Jun 21, 2022
Adeno-associated virus variant capsids and methods of use thereof
4D MOLECULAR THERAPEUTICS INC0 citations61
US11179477B2Nov 23, 2021
Method of using adeno-associated virus with variant capsid
4D MOLECULAR THERAPEUTICS INC0 citations61